¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Acid Control"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • methacrylic acid
    ¸ÞŸũ¸±»ê
  • methylhippuric acid
    ¸ÞÆ¿È÷Ǫ¸£»ê
  • N-acetylneuraminic acid
    N-¾Æ¼¼Æ¿´º¶ó¹Î»ê
  • neuraminic acid
    ´º¶ó¹Î»ê
  • neurostearic acid
    ½Å°æÁö¹æ»ê
  • nicotinic acid
    ´ÏÄÚÆ¾»ê
  • nitric acid
    Áú»ê
  • nitrobenzoic acid
    ´ÏÆ®·Îº¥Á¨»ê
  • nitrohydrochloric acid
    Áú¿°»ê, ¿Õ¼ö
  • nitrous acid
    ¾ÆÁú»ê
  • normal fatty acid
    Ç¥ÁØÁö¹æ»ê
  • nucleic acid
    ÇÙ»ê
  • nucleic acid probe
    ÇÙ»ê´õµëÀÚ
  • oleic acid
    ¿Ã·¹»ê
  • organic acid
    À¯±â»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • organic acid
    À¯±â»ê
  • oxalic acid
    ¿Á»ì»ê
  • oxaloacetic acid
    ¿Á»ì¾Æ¼¼Æ®»ê
  • pantoic acid
    ÆÇÅäÀλê
  • pantothenic acid
    ÆÇÅäÅÙ»ê
  • phenolic acid
    Æä³î»ê
  • phenolsulfuric acid
    Æä³îȲ»ê
  • phenylpyruvic acid
    Æä´ÒÇÇ·çºê»ê
  • phosphopyruvic acid
    Æ÷½ºÆ÷ÇÇ·çºê»ê
  • picramic acid
    ÇÇÅ©¶÷»ê
  • propionic acid
    ÇÁ·ÎÇǿ»ê
  • pyridoxic acid
    ÇǸ®µ¶½Å»ê
  • pyruvic acid
    ÇÇ·çºê»ê
  • retinoic acid
    ·¹Æ¼³ë»ê, ·¹Æ¼³ëÀλê
  • ribonucleic acid
    ¸®º¸ÇÙ»ê, ¾Ë¿£¿¡ÀÌ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • hyaluronic acid
    È÷¾Ë·ç·Ð»ê(¡­ß«).
  • hyaluronic acid
    ÇÏÀ̾ËÀ¯·Ð»ê(¡­ß«).
  • hybridization, nucleic acid
    ÇÙ»êºÎÇÕ¹ý(ݬùêÛö)
  • hydrochloric acid
    ¿°»ê
  • hydrochloric acid
    ¿°»ê(ç¤ß«)
  • hydrochloric acid milk
    ¿°»êÀ¯(¡­êá).
  • hydrocyanic acid
    È÷µå·Î½Ã¾È»ê(¡­ß«).
  • hydroferricyanic acid
    Æä¸®½Ã¾È»ê.
  • hydrofluoric acid
    ºÒÈ­ ¼ö¼Ò»ê(Ý×ûù â©áÈß«)
  • hydroparacumaric acid
    È÷µå·ÎÄí¸¶¸°»ê.
  • hydroxamic acid
    È÷µå·Ï»ï»ê(¡­ß«).
  • hydroxyindoleacetic acid = 5-HIAA
    5-ÇÏÀ̵å·Ï½ÃÀε¹ÃÊ»ê
  • indoxyl carbonic acid ester
    Àε¶½Çź»ê¿¡½ºÅ׸£
  • inosinic acid
    À̳ë½Å»ê.
  • phocenic acid
    ±æÃÊ»ê(ÑÎõ³ß«).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • acid-fast bacillus
    Ç×»ê±Õ(ù÷߫ж)
  • acid-fast stain
    Ç׻꼺 ¿°»ö
  • acid-fast stain
    Ç׻꼺¿°»ö(ù÷ß«àõæøßä)
  • acid<³ª> acidus
    »ê(ß«), »ê¼º(ß«àõ)ÀÇ.
  • adenylic acid deaminase
    ¾Æµ¥´Ò»ê Å»¾Æ¹Ì³ëÈ¿¼Ò.
  • aliphatic acid
    Áö¹æÁ·»ê(ò·Û¸ðéß«).
  • aliphatic amino acid
    Áö¹æÁ·¾Æ¹Ì³ë»ê
  • allokainic acid
    ¾Ë·ÎÄ«Àλê(¡­ß«).
  • aloetic acid
    ¾Ë·Î¿¡Æ¾»ê.
  • alpha-amino acid nitrogen
    ¾ËÆÄ-¾Æ¹Ì³ë»êÁú¼Ò
  • alpha1-acid glycoprotein
    ¾ËÆÄ-»ê´ç´Ü¹é
  • amino acid
    ¾Æ¹Ì³ë»ê
  • amino acid analyzer
    ¾Æ¹Ì³ë»êºÐ¼®±â
  • amino acid determination
    ¾Æ¹Ì³ë»ê°áÁ¤(̽ïÒ)
  • amino acid pattern
    ¾Æ¹Ì³ë»êÇüÅÂ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • hexuronic acid
    Çí½´·Ð »ê(ß«)
  • hippuric acid
    ¸¶´¢»ê(Ø©Òãß«)
  • homoamino acid
    È£¸ð¾Æ¹Ì³ë»ê(ß«)
  • homocodonic amino acid
    ±Õ(г)ÄÚµ· ¾Æ¹Ì³ë»ê(ß«)
  • homofermentative lactic acid bacteria
    µ¿Á¾¹ßÈ¿(ÔÒðúÛ£ý£) ¶ôÆ®»ê(ß«) ¹ÚÅ׸®¾Æ
  • homogentisic acid
    È£¸ðÁ¨Æ¾»ê(ß«)
  • hyaluronic acid
    ÇÏÀ̾ËÀ¯·Ð»ê(ß«)
  • hydroxy acid
    ÇÏÀ̵å·Ï½Ã»ê(ß«)
  • ¥â-hydroxybutyric acid
    ¥â-ÇÏÀ̵å·Ï½ÃºäƼ¸£»ê(ß«)
  • 5-hydroxyindoleacetic acid
    5-ÇÏÀ̵å·Ï½ÃÀε¹¾Æ¼¼Æ®»ê(ß«)
  • imino acid
    À̹̳ë»ê(ß«)
  • indispensable amino acid
    ºÒ°¡°á(ÝÕʦÌÀ) ¾Æ¹Ì³ë»ê(ß«)
  • indoleacetic acid
    Àε¹¾Æ¼¼Æ®»ê(ß«)
  • infectious nucleic acid
    °¨¿°¼ºÇÙ»ê(Êïæøàõú·ß«)
  • inosinic acid
    À̳ë½Å»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
ACC accommodation; acetyl coenzyme A carboxylase; acinic cell carcinoma; acute care center; adenoid cyst...
ACSE association control service element
ACT achievement through counseling and treatment; actin; actinomycin; activated clotting time; advanced ...
AGC absolute granulocyte count; automatic gain control
AMC academic medical center; acetylmethyl carbinol; Animal Medical Center; antibody-mediated cytotoxicit...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
SPC Statistical Process Control
SENIC Study of the Efficacy of Nosocomial Infection Control
TSCA Toxic Substance Control Act
TCP Tumor Control Probability
WKY Wistar Kyoto control
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • ribonucleic acid
    ¸®º¸ ÇÙ»ê
    È¿¸ð¿¡¼­ óÀ½À¸·Î ºÐ¸®µÈ ÇÙ»êÀ¸·Î ³ªÁß¿¡´Â ¸ðµç »ì¾ÆÀÖ´Â ¼¼Æ÷¿¡¼­µµ ¹ß°ßµÇ¾ú´Ù. °¡¼öºÐÇØÇÏ¸é ¾Æµ¥´Ñ, ±¸¾Æ´Ñ, »çÀÌÅä½Å, ¿ì¶ó½Ç, ¶ûº¸½º, ÀλêÀÌ »ý±ä´Ù. RNA¶ó ¾à±âÇÑ´Ù.
  • saccharic acid
    »çÄ«¸°»ê, ´ç»ê, »èÄ«¸°»ê
    1. ÀÌ¿°±â»ê. COOH,
  • salicylic acid test
    »ì¸®½Ç»ê ½ÃÇè
  • saturated fatty acid
    Æ÷È­ Áö¹æ»ê
  • serum bile acid
    Ç÷û ´ãÁó»ê
    ¹Ì·® Á¸ÀçÇÑ´Ù.
  • serum free fatty acid
    Ç÷û À¯¸® Áö¹æ»ê Á¤·®
    Á¤»óÄ¡´Â Á¶±â °øº¹ ½Ã 200-600¥ìEq/l·Î »ý¸®Àû º¯µ¿ÀÌ Å©´Ù.
  • serum uric acid
    Ç÷û ´¢»ê
    Åëdz, ½ÅºÎÀü, ¹éÇ÷º´ µîÀ¸·Î °í´¢»êÁõÀÌ »ý±ä´Ù.
  • sialic acid
    Ÿ¾×»ê
    ¸¹Àº ¹ÂÄÚ ´Ù´ç·ù¿Í ´çÁöÁú Áß¿¡ Á¸ÀçÇÏ´Â ´º¶ó¹Î»êÀÇ À¯µµÃ¼.
  • silicic acid
    ±Ô»ê
    ±Ô¼Ò¸¦ ¿°±â·Î ÇÏ¿© ±Ô»ê¿°À» Çü¼ºÇÏ´Â °ÍÀ¸·Î ortho ±Ô»ê, meta ±Ô»ê,
  • silicic acid anhydride
    ¹«¼ö ±Ô»ê
  • silicotungstic acid
    ½Ç¸®ÄÚ ÅÖ½ºÅÙ»ê
    ¹é»ö ¶Ç´Â Ȳ»öÀÇ °áÁ¤. ¾ËÄ®·ÎÀÌµå ½Ã¾àÀ¸·Î ¾²ÀδÙ.
  • sorbic acid
    ¼Ò¸£ºó»ê
    sorbus aucu
  • sugar acid
    ´ç»ê
  • sulfur-containing amino acid
    Ȳ ÇÔÀ¯ ¾Æ¹Ì³ë»ê
  • sulfuric acid
    Ȳ»ê
    ¹Ðµµ°¡ ³ô°í ±â¸§°ú °°ÀÌ º¸ÀÌ´Â ¾×üÀÇ »êÀε¥ ¼ö¼Ò, À¯È², »ê¼Ò·Î ±¸¼ºµÇ¾úÀ¸¸ç Ä¡°ú ±â°ø¿¡¼­´Â µ¿·®ÀÇ ¹°°ú È¥ÇÕÇÏ¿© ÁÖÁ¶¹° ¼¼Ã´ ¿ë¾×À¸·Î »ç¿ëÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
aminoacetic acid <amino acid, physiology> The simplest amino acid. It is a common residue in proteins, especially collagen and elastin and is not optically active.
It is also a major inhibitory neurotransmitter in spinal cord and brainstem of vertebrate central nervous system.
(18 Nov 1997)
amino acid <biochemistry> A class of organic molecules that containing an amino group and can combine in linear arrays to form proteins in living organisms.
There are twenty common amino acids: alanine, arginine, aspargine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine.
They are key components in all living things from which proteins are synthesised by formation of peptide bonds during ribosomal translation of messenger RNA.
All the amino acids have the L configuration, except glycine which is not optically active. Other amino acids occurring in proteins, such as hydroxyproline in collagen, are formed by post translational enzymatic modification of amino acid residues in polypeptide chains.
There are also several important amino acids, such as the neurotransmitter y aminobutyric acid, that have no relation to proteins.
Amino acids can now be produced by biotechnology in bulk using fermentation and biotransformation.
Acronym: AA
(13 Nov 1997)
amino acid activating enzyme <enzyme> Enzymes catalyzing the formation of a specific aminoacyl-tRNA from an amino acid and adenosine 5'-triphosphate with the concomitant formation of adenosine 5'-monophosphate and pyrophosphate.
Synonym: amino acid activating enzyme, aminoacyl-tRNA ligases.
(05 Mar 2000)
amino acid activation The first step of protein synthesis, whereby an amino acid reacts with adenosine triphosphate in the presence of aminoacyl RNA synthetase to produce an amino acid adenylate, which provides the energy necessary for the attachment of the amino acid to a specific transfer RNA molecule.
(12 Dec 1998)
amino acid analysis Determination and identification of amino acid content of a macromolecule, identification of a specific amino acid in macromolecules, often a mutated protein, identification and quantitation of amino acid content in blood plasma or urine; a key diagnostic aid.
(05 Mar 2000)
amino acid chloromethyl ketones <chemical> Inhibitors of serine proteinases and sulfhydryl group-containing enzymes. They act as alkylating agents and are known to interfere in the translation process.
Pharmacological action: alkylating agents, protein synthesis inhibitor, serine proteinase inhibitors.
(12 Dec 1998)
amino acid dehydrogenases Enzymes catalyzing the oxidative deamination of amino acids to the corresponding oxo (keto) acids; two relatively non-specific varieties exist, l and d, for which l-amino acids and d-amino acids are the respective substrates; the products include NH3 and a reduced hydrogen acceptor (NADH in the l case); amino acid dehydrogenases of greater specificity exist, (e.g., glycine dehydrogenase).
Compare: amino acid oxidases.
(05 Mar 2000)
amino acid isomerases <enzyme> Enzymes that catalyze either the racemization or epimerization of chiral centres within amino acids or derivatives.
Registry number: EC 5.1.1.-
(12 Dec 1998)
amino acid naphthylamidases <enzyme> Registry number: EC 3.4.11.
(12 Dec 1998)
amino acid neurotransmitters Amino acids released by neurons as intercellular messengers. Among the amino acid neurotransmitters are glutamate (glutamic acid) and gaba which are, respectively, the most common excitatory and inhibitory neurotransmitters in the central nervous system.
(12 Dec 1998)
amino acid oxidases Flavoenzymes oxidizing, with O2 and H20, either l-or d-amino acids specifically, to the corresponding 2-keto acids, NH3 and H2O2.
Compare: amino acid dehydrogenases, yellow enzyme.
(05 Mar 2000)
amino acid oxidoreductases <enzyme> A class of enzymes that catalyze oxidation-reduction reactions of amino acids.
Registry number: EC 1.4.
(12 Dec 1998)
amino acid permease <enzyme> A widely distributed group of large Integral membrane proteins, required for the entry of amino acids into cells.
(18 Nov 1997)
amino acid reagent A reagent used in the identification and quantification of amino acids.
(05 Mar 2000)
amino acid receptor <biochemistry> Ligand gated ion channels with specific receptors for amino acid transmitters. An extended protein superfamily that also includes subunits of the nicotinic acetylcholine receptor.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
ÅëÇÕ°Ë»ö ¿Ï·á